Effect of SPIE on reproductive hormone levels
The data on the serum levels of progesterone, estradiol and testosterone in control and different treatment groups are presented in Fig 2. Data discovered a significant reduction in progesterone, estradiol accompanied by a rapid increase in the testosterone levels in rats with PCOS when compared to the healthy control group. Diseased rats treated with clomiphene citrate showed a remarkable decrease in the testosterone levels and significant increase in the estradiol and progesterone levels when compared to PCOS group. Consistently, a minor regression in the levels of testosterone accompanied by a rapid increase in estradiol and levels of progesterone were noticed in PCOS rats treated with SPIE 100 mg compared to PCOS rats. Similar findings were observed in diseased rats treated with SPIE 200 mg with a major regression in the levels of testosterone. Moreover, the reproductive hormone levels in SPIE treated PCOS rats were comparable to that of control, in which SPIE 200 mg treated PCOS rats exhibited good results when compared.
Effect of SPIE on ovary weight of rats in PCOS model
The ovary (Left and right) weight of test animals of both control and different treatment groups were depicted in Fig 3. PCOS group exhibited significant increase in ovary weight when compared with the control. Whereas clomiphene citrate treated PCOS rats showed a significant reduction in the ovary weight in contrast to PCOS group. SPIE treated PCOS rats were comparable to that of healthy rats. It has been shown from the results that SPIE with a dose of 200 mg considered to be safer than other treatment groups.
Effect of SPIE on ovary histology study
Fig 4A and 4C, healthy tertiary follicle in the normal control and standard drug treated rats. The theca layers and granulosa layers appear normal. Fig 4B follicle in the early process of atresia with apoptotic granulosa cells, most of which are in the inner parts of the granulosa layer in a polycystic ovary syndrome (PCOS) rat. Thin and elongated epithelioid cells form the inner surface of the wall. The cyst fluid contains macrophages. Fig 4 D and E from a SPIE (100 and 200 mg) treated PCOS rat with normal tertiary follicles. (H & E staining; index bars, 50 μm)
Effect of SPIE on CYP17A1 and Ki 67 protein expression in immunology-assay
In Fig 5 the level of CYP17A1 and Ki 67 expression in control group was low compared to PCOS group. PCOS+100 mg expressed moderately reduced level when compared to control and PCOS. PCOS+CC and PCOS+200 mg expressed good reduced levels of protein expression when compared to control and PCOS group.
Immunohistochemistry of CYP17A1 and Ki 67 pictures is depicted in Fig 6 and 7(A-E). 6 and 7A-Signifies control group showing decreased level of CYP17A1. 6 and 7B-Signify the PCOS group with increased levels of CYP17A1. 6 and 7C and 6 and 7E Signify the treatment groups PCOS+CC and PCOS+SPIE 200 mg highlights the reduced levels of CYP17A1. 6 and 7D-signify the PCOS+SPIE100 mg with slight reduction in CYP17A1 levels.
Effect of SPIE on body weight of rats in PCOS model
The body weight of PCOS was significantly rising compared to control group. PCOS+CC group also showed significant weight reduction compared to PCOS group. PCOS+SPIE 100 mg and PCOS+SPIE200 mg showed very progressive weight reduction compared to PCOS group as in Fig 8.
The most prevalent hormonal disorder found in reproductive aged women is PCOS. The weight of ovary gets decreased in PCOS rats (
Song and Tan, 2016). On the contrary, a rapid increase in the ovary weight of PCOS group was observed in our study which was confirmed with the study of (
De Leo et al., 2016). This was supported by the study of
Louise et al., (2007) which showed an increase in ovary weight of Letrozole rats. Reduced aromatase effect might increase ovarian production of androgen and reduce oestrogen production, resulting to PCOS. Ovary weight found to be slightly higher in SPIE treatment rats when compared to the control in the present study. The present study also confirmed that SPIE treatment was mildly effective in normalizing the ovarian weight of rats when compared with PCOS group.
Many people with PCOS have higher insulin levels that can excite the ovaries to produce testosterone. Hyperan drogenism, particularly unbalanced testosterone levels are a key disturbance noticed in PCOS
(Azziz et al., 2006). Testosterone has relatively strong bond with globulin (66-78%) and weak bond with albumin (20-32%). Only 1-2% of the total pool of testosterone is not protein-bound and thus biologically active (
Mroczko and Medras, 2003). In PCOS women, free testosterone and free androgen index (FAI) are the markers of hyperandrogenism (
Rotterdam, 2003;
Conway et al., 2014). The levels of total testosterone in PCOS women might be normal or somewhat increased (maximal 5.2 nmol/L) (
Sheehan, 2004). The present study confirmed higher testosterone levels in PCOS rats which was reduced by an allopathic drug and further normalized with SPIE treatment. Higher levels of total testosterone are typical for tumours that synthetize androgens
(Conway et al., 2014). It was exposed that augmented levels of total testosterone in PCOS women, participates in the pathogenesis of atheroslerosis
(Hak et al., 2002). Progression of several reproductive defects related with PCOS, with disruption of cyclicity, higher levels of testosterone levelsand expression of enzymes involved in androgen biosynthesis, as well as ovulatory dysfunction, were found in a rat model with targeted deletion of Pcos particularly in ovarian theca cells
(Lan et al., 2017). NKB receptor antagonism in PCOS females were found to reduce LH pulse frequency and decrease serum LH as well as testosterone levels
(George et al., 2016).
Progesterone is considered to be the primary GnRH pulsatility regulator. The present investigation confirmed a reduction in the levels of progesterone in PCOS rats further increased with standard drug and SPIE treatment. It is identified that PCOS patients exhibit a GnRH-generating pulse resistance to negative feedback by progesterone, which leads to higher LH pulses frequency and/or amplitude
(Eagleson et al., 2000). Besides, LH excess is a variable PCOS feature, thus, it is hard to point the primary role to LH excess in the disease progression of all PCOS patients.
The effect of E
2 on granulosa cell GC function are not being clinically tested in PCOS women. Preclinical studies exhibited that higher estradiol concentration after ovarian stimulation,
(Homer et al., 2014), negatively affects endometrial receptiveness. The current investigation showed reduced levels of estradiol in PCOS rats can be increased by different treatment. In contrast, studies have connected higher levels of estradiol with altered gene expression during implantation and asynchrony among endometrial gland as well as stroma development. Data from clinical observations recommend that higher concentration of estradiol has an adverse action on pregnancy outcomes, after fresh embryo transfer. Though, PCOS women usually have a greater ovarian response for the stimulation and usually have more oocytes, along with a higher estradiol level, than ovulatory women
(Wei et al., 2018). The body weight of PCOS rats was significantly higher compared to control and treatment group
(Karatekea et al., 2018). Similar results were found in our study.
The melanin in the sepia ink, a carrier of dopamine prevents excess dilution of ink after ejection in water. (
Gabriella Fiore et al., 2004). Further studies implicit that Dopamine agonist effectively reduces the levels of Luteinizing hormone and testosterone levels (
Dirami and Cook 1998). The SPIE also contains melanin and dopamine that must have acted on the PCOS ovaries to reduce the levels of androgenic hormone and induced ovulation.
Dopamine agonist cabergoline, a safe and well established medicine was useful in prevention of ovarian hyperstimulation syndrome in PCOS women undergoing assisted reproduction
(Alvarezc et al., 2007). In the PCOS induced group the numbers of preantral follicles, antral follicles and corpus luteum decreased compared to the control groups. Treatment by Clomiphene citrate and SPIE increased the number of maturing ovarian follicles. Histological evaluation of ovaries revealed that thickness of granulosa and tunica albuginea increased, while thickness of theca layer deceased in the Pcos group compared to the control groups; however, consumption of SPIE and standard showed normal thickness of ovary layer. Immunoexpression of Ki-67 was higher in the theca interna cells and CYP17A1 in the interstitial and granulosa cells in the PCOS group (
Leonardo Augusto Lombardi et al., 2014). Similarly, in our study PCOS group had more Ki-67 and CYP17A1 Immunoexpression compared to control and treatment group.